术中神经根周围应用富血小板纤维蛋白对椎间盘突出术后残余神经病理性疼痛的影响:NeuroPRF随机对照试验研究方案
本研究为在斯特拉斯堡大学医院开展的前瞻性、干预性、随机、对照、单盲试验,比较常规手术与常规手术联合神经根周围应用富血小板纤维蛋白(PRF)两组各30例患者,主要结局为术后6个月神经病理性根性疼痛视觉模拟量表(VAS)强度,并分析神经病理性疼痛特征、生活质量、焦虑抑郁症状、镇痛药消耗及炎症细胞因子转录组。
要点
- 术后腰椎神经病理性根性疼痛患病率约30%,推荐治疗应答不佳,需探索预防慢性疼痛的新技术。
- PRF具有抗炎和镇痛特性,可能作为手术辅助减少神经源性炎症、促进神经恢复。
- 本研究为首个评估PRF预防椎间盘突出术后神经病理性疼痛疗效的随机对照试验。
核心结论
- 本研究旨在评估术中神经根周围应用PRF对椎间盘突出术后残余神经病理性疼痛的获益,并将提供神经病理性疼痛病理生理机制的信息。
研究设计与样本
- 随机、前瞻性、干预性、对照、单盲研究,由盲法结局评估者进行评估,在斯特拉斯堡大学医院开展。
- 对照组接受常规手术,试验组接受手术联合神经根周围应用PRF,每组30例患者。
主要发现
- 主要结局为术后6个月神经病理性根性疼痛强度,采用视觉模拟量表(VAS)测量。
- 次要结局包括神经病理性疼痛特征(NPSI)、生活质量(SF-12和PGIC)、焦虑抑郁症状(HAD)及镇痛药消耗。
- 将在术前和6个月随访时对血液样本中一组促炎和抗炎细胞因子进行转录组分析,并与临床数据(特别是术后神经病理性疼痛的出现)进行相关性分析。
临床怎么用
- 本研究为研究方案,原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevalence of post-surgical lumbar neuropathic radiculopathy is approximately 30%. Poor response to the recommended treatments for neuropathic pain, namely antidepressants and/or gabapentinoids, requires the development of new techniques to prevent chronic pain. One such well-tolerated technique is the administration of autologous plasma enriched in platelets and fibrin (PRF). This approach is largely used in regenerative medicine owing to the anti-inflammatory and analgesic properties of PRF. It could also be an interesting adjuvant to surgery, as it reduces neurogenic inflammation and promotes nerve recovery, thereby reducing the incidence of residual postoperative chronic pain. The aim of the present study is to evaluate the benefit of periradicular intraoperative application of PRF on the residual postsurgical neuropathic pain after disc herniation surgery. METHODS: A randomized, prospective, interventional, controlled, single-blind study with evaluation by a blind outcome assessor will be performed in Strasbourg University Hospital. We will compare a control group undergoing conventional surgery to an experimental group undergoing surgery and periradicular administration of PRF (30 patients in each arm). The primary outcome is the intensity of postoperative neuropathic radicular pain, measured by a visual analog scale (VAS) at 6 months post-surgery. The secondary outcomes are the characteristics of neuropathic pain (NPSI), the quality of life (SF-12 and PGIC), the presence of anxiety/depression symptoms (HAD), and the consumption of analgesics. We will also carry out transcriptomic analysis of a panel of pro- and anti-inflammatory cytokines in blood samples, before surgery and at 6 months follow-up. These gene expression results will be correlated with clinical data, in particular, with the apparition of postoperative neuropathic pain. DISCUSSION: This study is the first randomized controlled trial to assess the efficacy of PRF in the prevention of neuropathic pain following surgery for herniated disc. This study addresses not only a clinical question but will also provide information on the physiopathological mechanisms of neuropathic pain. TRIAL REGISTRATION: This study is registered at ClinicalTrials.gov: NCT05196503 , February 24, 2022.
引用
- Todeschi J, Dannhoff G, Coca AH, et al. Effect of an intraoperative periradicular application of platelet-rich fibrin (PRF) on residual post-surgical neuropathic pain after disc herniation surgery: study protocol for NeuroPRF, a randomized controlled trial. Trials. 2023. PMID: 37337269. doi:10.1186/s13063-023-07420-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。